Related Experiment Video
Updated: Jun 30, 2026
Precision-cut Mouse Lung Slices to Visualize Live Pulmonary Dendritic Cells
Published on: April 5, 2017
[Immunomorphological characteristics of pulmonary langerhans cell histiocytosis]
Insights
Langerhans cell histiocytosis (LCH) diagnosis in lung tissue is challenging. Researchers found Langerhans cells (LCs) undergo apoptosis, suggesting this as a potential therapeutic strategy for LCH.
Area of Science:
- Pulmonary pathology
- Immunohistochemistry
- Cell biology
Context:
- Langerhans cell histiocytosis (LCH) is a rare disorder affecting the lungs.
- Diagnosis of pulmonary LCH can be difficult due to tissue damage and artifacts from biopsies.
- Standard diagnostic methods rely on morphological and immunohistochemical analysis.
Purpose:
- To investigate the morphological and immunohistochemical characteristics of lung tissue in patients with LCH.
- To identify potential diagnostic markers and therapeutic targets in pulmonary LCH.
- To explore the behavior of Langerhans cells (LCs) within the lung microenvironment.
Summary:
- Lung tissue specimens from 27 LCH patients were analyzed using morphology and immunohistochemistry.
- Diagnosis was confirmed by CD1a and S-100 expression, crucial due to architectural distortion and biopsy artifacts.
- Langerhans cells (LCs) within the infiltrates were observed to undergo apoptosis.
Impact:
- Apoptosis induction in LCs presents a potential novel therapeutic strategy for managing pulmonary LCH.
- Improved understanding of LCH pathogenesis may lead to more effective treatment approaches.
- Highlights the importance of immunophenotyping for accurate LCH diagnosis in challenging lung biopsy cases.
Abstract:
Lung tissue specimens, obtained during lung biopsy or resection, were morphologically and immunohistochemically studied in 27 patients with Langerhans cell (LC) histiocytosis (LCH). The latter was diagnosed on the basis of the expression of CD1a and S-100. Without immunophenotyping, its diagnosis was difficult due to impaired tissue architectonics (sclerosis, bullous transformation) and artifacts that were inevitably present during lung biopsy. LCs in the infiltrates were shown to be capable for apoptosis. Induction of LC apoptosis may be regarded as a therapeutic strategy.
